로딩 중…
StockDiggingStockDigging

Dr. Reddy's Laboratories Limited

RDY· NYSE
ININ
$13.30+1.14%
2026-06-18

Price Chart

Dr. Reddy's Laboratories Limited-12.44%

Financials

※ FY = Fiscal Year

Investment Metrics(as of 2026-06-18)

MetricValue
Size
Market Cap$11.10B
Revenue$3.82B
Net Income$486M
Total Assets$6.02B
Net Assets$3.92B
Value
P/E22.85x
P/B2.83x
P/S2.91x
EV/EBITDA13.89x
FCF Yield2.48%
Profitability
ROE12.40%
ROA8.07%
Op. Margin14.74%
Revenue Growth-10.26%
Earnings Growth-85.98%
Financial Health
Debt Ratio52.75%
Total Debt$803M
FCF$275M
Cash$160M
Current Ratio1.80x
Net Debt/EBITDA0.76x
Dividend
Div. Yield0.68%
Div. Growth5.17%
Performance
1Y Return-12.44%
1M Return-1.12%
From 52W High-15.34%
1Y MDD-22.94%
Trading
Volume1,332,021 shares
Trading Value$18M